<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebrovascular complications were registered in 11 patients (0.21%) of 5,339, consecutively submitted to coronary angiography with the nonionic contrast medium <z:chebi fb="0" ids="31709">iohexol</z:chebi> (Omnipaque) </plain></SENT>
<SENT sid="1" pm="."><plain>Six of the patients had diseases predisposing them to thromboembolic complications, 3 of whom earlier had symptoms of cerebral <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Excluding these 6, the incidence of cerebral <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> was 0.10% in patients with no predisposing diseases </plain></SENT>
<SENT sid="3" pm="."><plain>Precise catheterization technique and some anticoagulation and antiplatelet activity therapy are definite precautions against these complications, while the role of the contrast medium is still debated </plain></SENT>
</text></document>